RxDoctor Payments Data

Patrick Hook, MD

Internal Medicine · Worcester, MANPI 1548420896

Payments from drug & device makers

$590in general payments, 2019–2025

Across 26 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$135
  • Johnson & Johnson$100
  • Urovant Sciences Inc$42
  • AstraZeneca$41
  • Sumitomo Pharma America, Inc.$40
  • Boehringer Ingelheim$29
  • plus $203 from 10 others

What the payments were for

  • Food & beverage$590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$590 in reported general payments places this provider in the 80th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$17,477
Medicare patients
164
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept58$414,138
Humira(Cf) PenAdalimumab40$363,628
Xeljanz XrTofacitinib Citrate56$309,231
RinvoqUpadacitinib24$153,154
Humira(Cf)Adalimumab22$143,889
EnbrelEtanercept13$93,206
Humira PenAdalimumab13$79,591
RasuvoMethotrexate/Pf17$10,253
MethotrexateMethotrexate Sodium267$9,776
Hydroxychloroquine Sulfate135$6,357
Prednisone459$3,779
Allopurinol130$1,794
Cyclobenzaprine Hcl61$1,615
Gabapentin62$1,293
Leucovorin Calcium12$957

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$28$93,20613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,983 internal medicine providers in Massachusetts.

Other internal medicine in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →